Get started
Author

Barbara K. Finck

Observed names: B Finck, B K Finck, B. Finck, Barbara Finck, Finck, Barbara
ORCID: 0000-0002-7913-767X
Observed ORCID: 0000-0002-7913-767X
OpenAlex ID: A5084906733
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 · Joan M. Bathon, Richard W. Martin, et al. · New England Journal of Medicine · 1,727
PDF
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
2000 · Philip J Mease, Bernard S Goffe, et al. · The Lancet · 1,438
Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes
2002 · Mark C. Genovese, Joan M. Bathon, et al. · Arthritis & Rheumatism · 729
Multicenter Prospective Study of Children With Sickle Cell Disease: Radiographic and Psychometric Correlation
2000 · F. Bernaudin, S. Verlhac, et al. · Journal of Child Neurology · 250
Long‐term efficacy and safety of etanercept in children with polyarticular‐course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open‐label, extended‐treatment trial
2003 · Daniel J. Lovell, Edward H. Giannini, et al. · Arthritis & Rheumatism · 248
Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.
1994 · B K Finck, B Chan, et al. · Journal of Clinical Investigation · 231
PDF
Enhanced Lymphoproliferation and Diminished Autoimmunity in CD4-deficient MRL/lprMice
1998 · Mark S. Chesnutt, Barbara K. Finck, et al. · Clinical Immunology and Immunopathology · 53
Pharmacokinetic and Pharmacodynamic Equivalence of Pegfilgrastim-cbqv and Pegfilgrastim in Healthy Subjects
2020 · Barbara Finck, Helen Tang, et al. · Advances in Therapy · 18
PDF
OP0226 Randomized, Double-Blind Study Comparing Chs-0214 with Etanercept in Patients with Active Rheumatoid Arthritis (RA) despite Methotrexate (MTX) Therapy
2016 · J. O'Dell, T. Takeuchi, et al. · Annals of the Rheumatic Diseases · 15
Randomized, single-blind, crossover study to assess the pharmacokinetic and pharmacodynamic bioequivalence of CHS-1701 to pegfilgrastim in healthy subjects.
2017 · John A. Glaspy, Paula G. O'Connor, et al. · Journal of Clinical Oncology · 9
Pharmacokinetic and Pharmacodynamic Bioequivalence of Pegfilgrastim-cbqv Delivered via a Prefilled Autoinjector and Prefilled Syringe in Healthy Male Participants
2023 · Hong Tang, Francesca Civoli, et al. · Advances in Therapy · 7
PDF
CHS-131, A Novel Once Daily Oral Treatment, Decreased Lesion Burden of Patients with Relapsing-Remitting Course of Multiple Sclerosis (RRMS) in a Randomized, Double-blind, Phase 2b, Multicenter Study (S50.002)
2017 · David Weinstein, Alexey Boyko, et al. · Neurology · 7
The role of T-cell subsets in the response to anti-CD3 monoclonal antibodies
1992 · Barbara K. Finck, Christianne M. Yung, et al. · Clinical Immunology and Immunopathology · 6
A Randomized, Open-Label Study Conducted to Evaluate the Bioequivalence of Pegfilgrastim-cbqv On-Body Injector Versus Prefilled Syringe in Healthy Male Participants
2024 · Hong Tang, Francesca Civoli, et al. · Advances in Therapy · 5
PDF
OP0220 Randomized, double-blind, global clinical trial to evaluate equivalence of CHS-1420 to adalimumab in patients with psoriasis and psoriatic arthritis
2017 · J O'Dell, A Kivitz, et al. · Annals of the Rheumatic Diseases · 3
SAT0162 Switching from etanercept to CHS-0214: a one year, randomized, double-blind study in patients with rheumatoid arthritis
2017 · J O'Dell, A Kivitz, et al. · Annals of the Rheumatic Diseases · 3
PDF
Letter to the Editor Regarding “The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence”
2021 · Barbara Finck, Robert B. Geller, et al. · Advances in Therapy · 2
PDF
A randomized, open-label, crossover study assessing the pharmacokinetic and pharmacodynamic bioequivalence of pegfilgrastim-cbqv via on-body injector vs prefilled syringe.
2022 · Hong Tang, Francesca Civoli, et al. · Journal of Clinical Oncology · 1
Works count: 21
Citation count: 4,752
H-index: 9
I10-index: 9
Year
Topic
Type